Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Reilly

Showing results (561-570 of 605) with videos related to

Pageof 61
Sort By:
The American Journal of Sports Medicine|January 19, 2002
Osseous adaptation and range of motion at the glenohumeral joint in professional baseball pitchersHeber C Crockett, Lyndon B Gross, Kevin E Wilk, et al.
Cell Death & Disease|February 5, 2016
ANP32B deficiency impairs proliferation and suppresses tumor progression by regulating AKT phosphorylationS Yang, L Zhou, P T Reilly, et al.
BMC Geriatrics|March 29, 2019
What is important to people living with dementia?: the 'long-list' of outcome items in the development of a core outcome set for use in the evaluation of non-pharmacological community-based health and social care interventionsAndrew J E Harding, Hazel Morbey, Faraz Ahmed, et al.
British Journal of Haematology|September 1, 1999
The management of 'low-risk' and 'intermediate-risk' patients with primary thrombocythaemia. MPD (UK) Study GroupT C Pearson, D Bareford, J Craig, et al.
British Journal of Haematology|June 18, 2014
Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemiaClaire N Harrison, Nauman Butt, Peter Campbell, et al.
Human Gene Therapy|March 17, 2004
A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicinLeisha A Emens, Deborah Armstrong, Barbara Biedrzycki, et al.
Blood|March 13, 2009
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conferenceGiovanni Barosi, Gunnar Birgegard, Guido Finazzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2011
Acidic nuclear phosphoprotein 32kDa (ANP32)B-deficient mouse reveals a hierarchy of ANP32 importance in mammalian developmentPatrick T Reilly, Samia Afzal, Chiara Gorrini, et al.
British Journal of Haematology|July 21, 2005
Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosisMary F McMullin, D Bareford, P Campbell, et al.
British Journal of Haematology|September 1, 1996
Intermediate-dose busulphan before autografting for advanced-phase chronic myeloid leukaemiaS A Rule, D G Savage, S G O'Brien, et al.
Pageof 61

Showing results (561-570 of 605) with videos related to

Sort By:
Pageof 61
The American Journal of Sports Medicine|January 19, 2002
Osseous adaptation and range of motion at the glenohumeral joint in professional baseball pitchersHeber C Crockett, Lyndon B Gross, Kevin E Wilk, et al.
Cell Death & Disease|February 5, 2016
ANP32B deficiency impairs proliferation and suppresses tumor progression by regulating AKT phosphorylationS Yang, L Zhou, P T Reilly, et al.
BMC Geriatrics|March 29, 2019
What is important to people living with dementia?: the 'long-list' of outcome items in the development of a core outcome set for use in the evaluation of non-pharmacological community-based health and social care interventionsAndrew J E Harding, Hazel Morbey, Faraz Ahmed, et al.
British Journal of Haematology|September 1, 1999
The management of 'low-risk' and 'intermediate-risk' patients with primary thrombocythaemia. MPD (UK) Study GroupT C Pearson, D Bareford, J Craig, et al.
British Journal of Haematology|June 18, 2014
Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemiaClaire N Harrison, Nauman Butt, Peter Campbell, et al.
Human Gene Therapy|March 17, 2004
A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicinLeisha A Emens, Deborah Armstrong, Barbara Biedrzycki, et al.
Blood|March 13, 2009
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conferenceGiovanni Barosi, Gunnar Birgegard, Guido Finazzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2011
Acidic nuclear phosphoprotein 32kDa (ANP32)B-deficient mouse reveals a hierarchy of ANP32 importance in mammalian developmentPatrick T Reilly, Samia Afzal, Chiara Gorrini, et al.
British Journal of Haematology|July 21, 2005
Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosisMary F McMullin, D Bareford, P Campbell, et al.
British Journal of Haematology|September 1, 1996
Intermediate-dose busulphan before autografting for advanced-phase chronic myeloid leukaemiaS A Rule, D G Savage, S G O'Brien, et al.
Pageof 61